Big Pharma Collaborating On Big Data To Improve Health

In this video, Steve Forbes hosts Sir Andrew Witty from GlaxoSmithKline in a discussion on how data and data sharing is having a profound impact on people’s health around the world.

Traditionally, big pharma kept their data and results under lock and key. Now, with a global population impatient to find answers and cures, the industry is working together to affect change.

Resource Links: